Engineers Gate Manager LP Nektar Therapeutics Transaction History

Engineers Gate Manager LP

$3.68 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $41,826 - $88,185	20,604 New	20,604 $46,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $178,810 - $348,031	-56,407 Reduced 39.35%	86,957 $330,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $532,621 - $1.76 Million	128,034 Added 835.19%	143,364 $773,000
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $166,023 - $282,225	15,330 New	15,330 $207,000
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $1.69 Million - $2.43 Million	-129,105 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $1.65 Million - $2.04 Million	100,174 Added 346.25%	129,105 $2.22 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $1.86 Million - $2.86 Million	-112,464 Reduced 79.54%	28,931 $579,000
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $1.69 Million - $2.04 Million	107,002 Added 311.12%	141,395 $2.4 Million
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $332,695 - $497,138	20,054 Added 139.86%	34,393 $571,000
Q2 2020 Aug 17, 2020	SELL	$16.86 - $23.44 $416,273 - $578,733	-24,690 Reduced 63.26%	14,339 $332,000
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $315,865 - $610,338	21,829 Added 126.91%	39,029 $697,000
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $1.92 Million - $2.8 Million	-120,942 Reduced 87.55%	17,200 $371,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $2.11 Million - $4.52 Million	124,664 Added 924.94%	138,142 $2.52 Million
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $107,322 - $125,670	-3,462 Reduced 20.44%	13,478 $479,000
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $534,965 - $785,169	16,940 New	16,940 $569,000

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$23.7 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$15.5 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$9.76 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.99 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$7.58 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account